FDA Clears Invokana for CV Prevention in T2D
(MedPage Today) -- First oral diabetes drug to win this indication
Source: MedPage Today Public Health - Category: American Health Source Type: news
More News: American Health | Canagliflozin | Diabetes | Endocrinology | International Medicine & Public Health | Invokana